A detailed history of Alliancebernstein L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Alliancebernstein L.P. holds 5,057,736 shares of LLY stock, worth $3.77 Billion. This represents 1.56% of its overall portfolio holdings.

Number of Shares
5,057,736
Previous 4,870,677 3.84%
Holding current value
$3.77 Billion
Previous $4.41 Billion 1.61%
% of portfolio
1.56%
Previous 1.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $144 Million - $180 Million
187,059 Added 3.84%
5,057,736 $4.48 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $60.2 Million - $75.5 Million
83,103 Added 1.74%
4,870,677 $4.41 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $163 Million - $218 Million
-274,727 Reduced 5.43%
4,787,574 $3.72 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $77.1 Million - $90.8 Million
146,722 Added 2.98%
5,062,301 $2.95 Billion
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $78.8 Million - $109 Million
181,351 Added 3.83%
4,915,579 $2.64 Billion
Q2 2023

Aug 15, 2023

BUY
$350.74 - $468.98 $63.4 Million - $84.8 Million
180,714 Added 3.97%
4,734,228 $2.22 Billion
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $798 Million - $937 Million
2,568,469 Added 129.39%
4,553,514 $1.56 Billion
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $44.8 Million - $52.2 Million
-139,254 Reduced 6.56%
1,985,045 $726 Million
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $17 Million - $19.4 Million
57,286 Added 2.77%
2,124,299 $687 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $26.7 Million - $31.4 Million
95,909 Added 4.87%
2,067,013 $670 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $15 Million - $18.6 Million
-63,813 Reduced 3.14%
1,971,104 $564 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $28 Million - $34.7 Million
-124,357 Reduced 5.76%
2,034,917 $562 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $27.1 Million - $33.4 Million
122,425 Added 6.01%
2,159,274 $499 Million
Q2 2021

Jul 30, 2021

BUY
$180.55 - $233.54 $21.8 Million - $28.2 Million
120,812 Added 6.31%
2,036,849 $467 Million
Q1 2021

May 06, 2021

SELL
$164.32 - $212.72 $71 Million - $91.9 Million
-431,859 Reduced 18.39%
1,916,037 $358 Million
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $21 Million - $27.7 Million
-160,623 Reduced 6.4%
2,347,896 $396 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $13 Million - $15.1 Million
-89,206 Reduced 3.43%
2,508,519 $371 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $11.6 Million - $13.9 Million
-84,883 Reduced 3.16%
2,597,725 $426 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $128 Million - $159 Million
-1,078,646 Reduced 28.68%
2,682,608 $372 Million
Q4 2019

Feb 18, 2020

SELL
$106.92 - $132.43 $124 Million - $153 Million
-1,155,529 Reduced 23.5%
3,761,254 $494 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $50 Million - $54.4 Million
468,455 Added 10.53%
4,916,783 $550 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $134 Million - $156 Million
1,205,957 Added 37.19%
4,448,328 $493 Million
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $81.2 Million - $95.5 Million
729,098 Added 29.01%
3,242,371 $421 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $18.9 Million - $21.2 Million
-178,395 Reduced 6.63%
2,513,273 $291 Million
Q3 2018

Nov 08, 2018

SELL
$85.86 - $107.31 $34.9 Million - $43.7 Million
-406,909 Reduced 13.13%
2,691,668 $289 Million
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $4.38 Million - $5.03 Million
57,850 Added 1.9%
3,098,577 $264 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $97.3 Million - $115 Million
-1,310,932 Reduced 30.12%
3,040,727 $235 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $29.9 Million - $32.1 Million
365,011 Added 9.16%
4,351,659 $368 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $307 Million - $341 Million
3,986,648
3,986,648 $341 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.